Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The 4th affiliated hospital of China Medical Univ. LSD1 compound L8
- Development stage
- Preclinical
- Lead developer
- The Fourth Hospital of China Medical University
01
Overview
The 4th affiliated hospital of China Medical Univ. LSD1 compound L8: sourced facts only. name: "Compound L8 as a selective and reversible LSD1 inhibitor could inhibit LSD1 with the IC50 value of 60 nM." [PMID:35350943]; target: "Compound L8 as a selective and reversible LSD1 inhibitor could inhibit LSD1 with the IC50 value of 60 nM." [PMID:35350943]; developer: "Department of Urology, The 4th affiliated hospital of China Medical University, Shenyang, PR China." [PMID:35350943]; stage: "sulphonamide derivative L8 exhibited the antiproliferative activity against HTB5, HTB3, HT1376, and HTB1 cells with IC50 values of 1.87, 0.18, 0.09, and 0.93 μM, respectively." [PMID:35350943]
02
Targets
KDM1A (LSD1)
Beyond the preview
Go deeper on The 4th affiliated hospital of China Medical Univ. LSD1 compound L8.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on The 4th affiliated hospital of China Medical Univ. LSD1 compound L8.